Significant Accounting Policies (Tables)

9 Months Ended

Sep. 30, 2015

Summary of Fair Value Accumulated Other Comprehensive Income and Intraperiod Tax Allocation in Available-for-Sale Marketable Securities

The following table summarizes the fair value, accumulated other comprehensive income and intra-period tax allocation regarding the Company’s investment in REGENXBIO, at September 30, 2015.

In thousands	2015
Accumulated other comprehensive income, before tax	$	15,138
Intra-period tax allocation recorded as a benefit from income taxes		(6,086	)
Accumulated other comprehensive income, net of tax	$	9,052

Summary of Product Revenue Allowances and Reserve Categories

The following table summarizes the activity in each of the above product revenue allowances and reserve categories for the nine-month period ended September 30, 2015:

In thousands	Trade Allowances			Rebates, Chargebacks and Discounts			Other Adjustments			Total
Balance, January 1, 2015	$	72		$	2,095		$	360		$	2,527
Provision		255			2,097			218			2,570
Payments or credits		(228	)		(1,645	)		(158	)		(2,031	)
Balance, March 31, 2015		99			2,547			420			3,066
Provision		304			3,262			228			3,794
Payments or credits		(289	)		(2,808	)		(62	)		(3,159	)
Balance, June 30, 2015		114			3,001			586			3,701
Provision		298			3,997			92			4,387
Payments or credits		(302	)		(3,314	)		(219	)		(3,835	)
Balance, September 30, 2015	$	110		$	3,684		$	459		$	4,253